Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study) is a clinical trial[1].
Key Facts
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study) is in the country of Australia[2].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s instance of is recorded as clinical trial[3].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s start time is recorded as +2019-07-31T00:00:00Z[4].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s end time is recorded as +2022-07-31T00:00:00Z[5].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s contributor to the creative work or subject is recorded as Bristol-Myers Squibb[6].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s sponsor is recorded as Melanoma Institute Australia[7].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s main subject is recorded as melanoma[8].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s number of participants is recorded as {'unit': '1', 'amount': '+218'}[9].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s title is recorded as A Phase II, Open Label, Randomised, Controlled Trial of Ipilimumab and Nivolumab With Concurrent Intracranial Stereotactic Radiotherapy Versus Ipilimumab and Nivolumab Alone in Patients With Melanoma Brain Metastases.[10].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s short name is recorded as ABC-X[11].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[12].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s ClinicalTrials.gov ID is recorded as NCT03340129[13].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+120'}[14].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s clinical trial phase is recorded as phase II clinical trial[15].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s research site is recorded as Westmead Hospital[16].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s research site is recorded as Melanoma Institute Australia[17].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s research site is recorded as Princess Alexandra Hospital[18].
- Anti-PD 1 Brain Collaboration + Radiotherapy (ABC-X Study)'s study type is recorded as interventional study[19].